Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response

Typeset version

 

TY  - JOUR
  - Turroni, F,Taverniti, V,Ruas-Madiedo, P,Duranti, S,Guglielmetti, S,Lugli, GA,Gioiosa, L,Palanza, P,Margolles, A,van Sinderen, D,Ventura, M
  - 2014
  - January
  - Applied and Environmental Microbiology
  - Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response
  - Validated
  - Altmetric: 1 ()
  - HEAT-SHOCK PROTEINS INTESTINAL EPITHELIAL-CELLS CACO-2 CELLS GENE-EXPRESSION IN-VITRO LACTOBACILLUS-ACIDOPHILUS COLORECTAL-CARCINOMA ULCERATIVE-COLITIS DENDRITIC CELLS GENOME ANALYSIS
  - 80
  - 730
  - 740
  - Here, we describe data obtained from transcriptome profiling of human cell lines and intestinal cells of a murine model upon exposure and colonization, respectively, with Bifidobacterium bifidum PRL2010. Significant changes were detected in the transcription of genes that are known to be involved in innate immunity. Furthermore, results from enzyme-linked immunosorbent assays (ELISAs) showed that exposure to B. bifidum PRL2010 causes enhanced production of interleukin 6 (IL-6) and IL-8 cytokines, presumably through NF-kappa B activation. The obtained global transcription profiles strongly suggest that Bifidobacterium bifidum PRL2010 modulates the innate immune response of the host.
  - 10.1128/AEM.03313-13
DA  - 2014/01
ER  - 
@article{V243939799,
   = {Turroni,  F and Taverniti,  V and Ruas-Madiedo,  P and Duranti,  S and Guglielmetti,  S and Lugli,  GA and Gioiosa,  L and Palanza,  P and Margolles,  A and van Sinderen,  D and Ventura,  M },
   = {2014},
   = {January},
   = {Applied and Environmental Microbiology},
   = {Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response},
   = {Validated},
   = {Altmetric: 1 ()},
   = {HEAT-SHOCK PROTEINS INTESTINAL EPITHELIAL-CELLS CACO-2 CELLS GENE-EXPRESSION IN-VITRO LACTOBACILLUS-ACIDOPHILUS COLORECTAL-CARCINOMA ULCERATIVE-COLITIS DENDRITIC CELLS GENOME ANALYSIS},
   = {80},
  pages = {730--740},
   = {{Here, we describe data obtained from transcriptome profiling of human cell lines and intestinal cells of a murine model upon exposure and colonization, respectively, with Bifidobacterium bifidum PRL2010. Significant changes were detected in the transcription of genes that are known to be involved in innate immunity. Furthermore, results from enzyme-linked immunosorbent assays (ELISAs) showed that exposure to B. bifidum PRL2010 causes enhanced production of interleukin 6 (IL-6) and IL-8 cytokines, presumably through NF-kappa B activation. The obtained global transcription profiles strongly suggest that Bifidobacterium bifidum PRL2010 modulates the innate immune response of the host.}},
   = {10.1128/AEM.03313-13},
  source = {IRIS}
}
AUTHORSTurroni, F,Taverniti, V,Ruas-Madiedo, P,Duranti, S,Guglielmetti, S,Lugli, GA,Gioiosa, L,Palanza, P,Margolles, A,van Sinderen, D,Ventura, M
YEAR2014
MONTHJanuary
JOURNAL_CODEApplied and Environmental Microbiology
TITLEBifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response
STATUSValidated
TIMES_CITEDAltmetric: 1 ()
SEARCH_KEYWORDHEAT-SHOCK PROTEINS INTESTINAL EPITHELIAL-CELLS CACO-2 CELLS GENE-EXPRESSION IN-VITRO LACTOBACILLUS-ACIDOPHILUS COLORECTAL-CARCINOMA ULCERATIVE-COLITIS DENDRITIC CELLS GENOME ANALYSIS
VOLUME80
ISSUE
START_PAGE730
END_PAGE740
ABSTRACTHere, we describe data obtained from transcriptome profiling of human cell lines and intestinal cells of a murine model upon exposure and colonization, respectively, with Bifidobacterium bifidum PRL2010. Significant changes were detected in the transcription of genes that are known to be involved in innate immunity. Furthermore, results from enzyme-linked immunosorbent assays (ELISAs) showed that exposure to B. bifidum PRL2010 causes enhanced production of interleukin 6 (IL-6) and IL-8 cytokines, presumably through NF-kappa B activation. The obtained global transcription profiles strongly suggest that Bifidobacterium bifidum PRL2010 modulates the innate immune response of the host.
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URL
DOI_LINK10.1128/AEM.03313-13
FUNDING_BODY
GRANT_DETAILS